As of close of business last night, Adicet Bio Inc’s stock clocked out at $2.36, down -1.67% from its previous closing price of $2.40. In other words, the price has decreased by -$0.0400 from its previous closing price. On the day, 1535297 shares were traded.
Ratios:
To gain a deeper understanding of ACET’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.41 and its Current Ratio is at 8.41. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
JP Morgan Downgraded its Overweight to Neutral on June 01, 2023, whereas the target price for the stock was revised from $20 to $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 25 ’24 when ORBIMED ADVISORS LLC bought 3,125,000 shares for $2.40 per share. The transaction valued at 7,500,000 led to the insider holds 7,526,359 shares of the business.
GORDON CARL L bought 3,125,000 shares of ACET for $7,500,000 on Jan 25 ’24. The Director now owns 7,526,359 shares after completing the transaction at $2.40 per share. On Oct 02 ’23, another insider, Schor Chen, who serves as the President & CEO of the company, bought 5,500 shares for $1.33 each. As a result, the insider paid 7,340 and bolstered with 43,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 193.06M and an Enterprise Value of 54.27M. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is -0.40.
Stock Price History:
The Beta on a monthly basis for ACET is 1.86, which has changed by -56.93% over the last 52 weeks, in comparison to a change of 27.27% over the same period for the S&P500. Over the past 52 weeks, ACET has reached a high of $7.50, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 2.5574, while the 200-Day Moving Average is calculated to be 2.1426.
Shares Statistics:
It appears that ACET traded 1.79M shares on average per day over the past three months and 1.03M shares per day over the past ten days. A total of 82.15M shares are outstanding, with a floating share count of 67.15M. Insiders hold about 18.27% of the company’s shares, while institutions hold 43.06% stake in the company. Shares short for ACET as of Mar 15, 2024 were 5.81M with a Short Ratio of 3.25, compared to 4.75M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.08% and a Short% of Float of 8.20%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.51, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.27 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$1.09 and -$3.05 for the fiscal current year, implying an average EPS of -$1.86. EPS for the following year is -$1.88, with 7 analysts recommending between -$1.05 and -$3.41.
